I now have excellent comprehensive content from multiple authoritative surgical and gastroenterology textbooks. I have enough to compose a thorough, well-structured response.
Management of Acute Calculous Cholecystitis
Acute calculous cholecystitis (ACC) — gallstone-induced gallbladder inflammation — results from cystic duct obstruction by a gallstone in >90% of cases, followed by distension, ischemia, bacterial overgrowth, and, if untreated, gangrene or perforation.
1. Diagnosis
Clinical Features
- RUQ or epigastric pain (constant, >6 hours), fever, nausea/vomiting
- Murphy's sign: inspiratory arrest on deep palpation of the RUQ (sonographic Murphy's sign is operator-dependent)
- Leukocytosis; mild elevations of ALP, bilirubin, and transaminases
- Profound jaundice is rare — if present, suspect cholangitis or Mirizzi syndrome
Imaging
| Modality | Sensitivity | Specificity | Role |
|---|
| RUQ Ultrasound (first choice) | 85–94% | 78–95% | Gallstones, wall thickening (>4 mm), pericholecystic fluid, sonographic Murphy's sign |
| HIDA scan | 96% | 90% | Non-filling of gallbladder = cystic duct obstruction; gold standard when US inconclusive |
| CT abdomen | High | High | Emphysematous cholecystitis, perforation, pericholecystic abscess, peritonitis |
| MRI/MRCP | High | High | Reserved for suspected choledocholithiasis or malignancy |
RUQ ultrasound is the diagnostic test of choice. CT is recommended when emphysematous cholecystitis or complications are suspected. — Sabiston Textbook of Surgery
2. Tokyo Guidelines 2018 (TG18) — Severity Grading
The TG18 framework is the most widely used system for risk-stratifying patients and guiding treatment:
| Grade | Severity | Criteria |
|---|
| Grade I (Mild) | No organ dysfunction; mild inflammation | Uncomplicated; manageable with standard care |
| Grade II (Moderate) | Marked local inflammation | WBC >18,000/mm³; symptom duration >72 h; palpable tender mass; marked pericholecystic inflammation on imaging; no organ dysfunction |
| Grade III (Severe) | Organ dysfunction | Cardiovascular (hypotension requiring vasopressors), neurological (decreased consciousness), respiratory (PaO₂/FiO₂ <300), renal (oliguria, Cr >2.0), hepatic (PT-INR >1.5), hematologic (platelet <100,000/mm³) |
The AAST EGS grading (Grades I–V) runs parallel to TG18, with Grade V denoting pericholecystic abscess, bilioenteric fistula, and peritonitis. — Sabiston Textbook of Surgery
3. Initial Resuscitation and Supportive Care
All patients require:
- IV fluid resuscitation — restore perfusion and electrolyte balance
- NPO (nothing by mouth)
- Parenteral analgesia (narcotics for pain control)
- IV antibiotics — bile cultures positive in >40% of patients
Antibiotic Selection
- Mild–moderate (Grade I–II): Cefoxitin (2nd-gen cephalosporin) or ampicillin-sulbactam
- Severe (Grade III) or broad-spectrum needed: Piperacillin-tazobactam or 3rd-generation cephalosporin + metronidazole
- Emphysematous/gangrenous cholecystitis: Must cover anaerobes (metronidazole or piperacillin-tazobactam)
- Organisms targeted: E. coli, Klebsiella, Enterobacter, Proteus (gram-negative enteric bacilli); Enterococcus, Streptococcus (gram-positive); anaerobes (~15% of isolates); Clostridium in emphysematous disease
If source control is achieved with surgery, postoperative antibiotics are NOT indicated for mild-to-moderate cholecystitis. Continue antibiotics postoperatively for severe infection, intraoperative gallbladder perforation, or gangrenous cholecystitis. — Sleisenger & Fordtran's GI and Liver Disease
4. Definitive Treatment: Cholecystectomy
Timing: Early vs. Delayed
Multiple RCTs have definitively resolved the old debate. Early laparoscopic cholecystectomy (within 72 hours of presentation) is the standard of care for surgically fit patients.
| Outcome | Early Cholecystectomy | Delayed (6–8 weeks) |
|---|
| Mortality | 0% | 2.0% |
| Total hospital stay | 9.6 days | 17.8 days |
| Failure requiring urgent surgery | N/A | 26% |
| Bile duct injuries | 0 | 0 |
Combined results from 7 randomized trials (n=742). — Sleisenger & Fordtran's GI and Liver Disease, p. 1263
Key insight: With delayed surgery, 26% of patients deteriorated and required urgent unplanned operation — the worst surgical scenario.
Surgical Approach
- Laparoscopic cholecystectomy is feasible in most cases and is the procedure of choice
- If severe inflammation obscures the hepatocystic triangle: laparoscopic subtotal fenestrating cholecystectomy or conversion to open
- Intraoperative cholangiography is especially valuable in acute cholecystitis to confirm ductal anatomy and detect CBD stones
- Routine placement of surgical drainage catheters after laparoscopic cholecystectomy is not warranted and may be harmful
Management Algorithm (Mulholland & Greenfield's Surgery, Algorithm 8.2)
Algorithm 8.2: For acute cholecystitis — admit to surgery, start IV antibiotics, laparoscopic cholecystectomy within 24 hours (or within 48 hrs if concurrent cholangitis requiring ERCP first). From Mulholland & Greenfield's Surgery, 7e.
5. Non-Surgical Options for High-Risk Patients
When the patient is not a surgical candidate (severe comorbidities: cardiac, hepatic, pulmonary failure):
Percutaneous Cholecystostomy (PC)
- Gallbladder drainage performed under ultrasound or fluoroscopic guidance
- TG18 recommends PC for Grade II–III cholecystitis in high-surgical-risk patients failing antibiotics and supportive care
- Earlier TG versions specified: Grade II with symptoms >72 h failing antibiotics, OR any Grade III
- 30-day mortality after PC: 9–21% (reflecting the severity of underlying illness)
- Residual stones can be removed via the tube; however, ~50% of patients develop recurrent biliary symptoms
- After recovery, interval laparoscopic cholecystectomy should be performed if the patient's condition permits
Endoscopic Transmural Gallbladder Drainage
- EUS-guided endoluminal stent from gallbladder to duodenum (EUS-GBD)
- As effective as percutaneous drainage for decompression in non-surgical patients
- Caveat: If future surgery becomes possible, it requires additional repair of the duodenotomy site — so it is reserved for patients who will definitively remain non-surgical candidates
6. Special Populations
| Population | Key Consideration |
|---|
| Diabetic patients | Higher risk of sepsis, empyema, gangrene → perform cholecystectomy expeditiously |
| Elderly patients | Deceptively benign presentation; high rates of occult gangrene and empyema → early cholecystectomy warranted |
| Pregnancy | Laparoscopic cholecystectomy is safe and preferred over non-operative management (recent 2025 meta-analysis, PMID 40610639) |
| Gangrenous/emphysematous cholecystitis | Risk factors: male sex, DM, cardiovascular disease, WBC >15,000/mm³ → add anaerobic coverage; urgent surgery |
7. Complications to Recognize and Manage
| Complication | Features | Management |
|---|
| Gangrenous cholecystitis | Necrosis of gallbladder wall; high WBC, DM, male sex, CV disease | Urgent cholecystectomy + anaerobic antibiotics |
| Emphysematous cholecystitis | Gas in gallbladder wall on CT; Clostridium species | Urgent surgery; clostridial coverage |
| Perforation / pericholecystic abscess | Peritoneal signs, CT confirms | Urgent surgery or PC + antibiotics |
| Mirizzi syndrome | Stone in cystic duct/Hartmann's pouch compressing common hepatic duct → jaundice | MRCP; surgical biliary reconstruction |
| Empyema | Pus-filled gallbladder; spiking fevers, severe illness | Urgent cholecystectomy or PC drainage |
8. Summary Algorithm
Acute Calculous Cholecystitis Confirmed
↓
IV fluids + NPO + Analgesia + IV Antibiotics
↓
Assess Severity (TG18 Grade I / II / III)
+ Surgical Risk (ASA / comorbidities)
↓
┌─────────────────────────────────┐
│ Grade I–II, Low surgical risk │ → Early Laparoscopic Cholecystectomy
│ │ (within 72 hours, ideally 24–48 h)
└─────────────────────────────────┘
↓
┌─────────────────────────────────────────┐
│ Grade II–III, High surgical risk │ → Percutaneous Cholecystostomy
│ (organ failure, severe comorbidities) │ + Antibiotics
└─────────────────────────────────────────┘
↓ (after recovery)
Interval Laparoscopic Cholecystectomy
(if patient becomes operative candidate)
Key Sources:
- Sleisenger & Fordtran's GI and Liver Disease, Ch. 90, p. 1263
- Sabiston Textbook of Surgery, Ch. Biliary, pp. 1824–1831
- Mulholland & Greenfield's Surgery, 7e, pp. 461–462
- Current Surgical Therapy, 14e, pp. 510–511
- Tokyo Guidelines 2018 (TG18)
Recent Evidence Note: A 2025 systematic review (PMID 40610639) confirms operative management is preferred over non-operative treatment for acute cholecystitis in pregnancy. A 2024 meta-analysis (PMID 38758253) found CT has comparable diagnostic accuracy to ultrasound but US remains first-line due to cost, availability, and radiation avoidance.